emergenresearch

The global  next generation sequencing (NGS) sample preparation Market  is expected to reach USD 6,630.0 Million by 2027, according to a new report by Emergen Research. Numerous advantages of high-performance sequencing compared to technologies used in the field of genetics, including microarray and sanger-seq, are among the significant factors fueling the NGS sample preparation market growth. In addition, it is estimated that the availability of sampling techniques with low input DNA reduces overall costs is that, expanding the use of next-generation sequencing in various scientific and clinical applications. The latest report provides detailed insights into Next Generation Sequencing Sample Preparation market trends, industry trends, consumer trends, market size, market share, market growth, and forecast, along with ranging impact of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the...

The global  pharmacovigilance market  is expected to be worth USD 12.48 Billion by 2027, according to a current analysis by Emergen Research. The market for pharmacovigilance is experiencing rapid growth attributed to a rise in application for spontaneous reporting, electronic health record (HER) mining, cohort event monitoring, and intensified adverse drug reaction (ADR) reporting, among others. The pharmacovigilance primarily emphasizes on on ADR (adverse drug reactions) and cases of drug toxicity. The latest report provides detailed insights into Pharmacovigilance market trends, industry trends, consumer trends, market size, market share, market growth, and forecast, along with ranging impact of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2020–2028. The report includes profiles of major players in the Pharmacovigilance market, strategies being employed, merge...